FDA Clears BTL’s Emsculpt Neo for Muscle Rehab
The Dermatology Digest
OCTOBER 12, 2024
The U.S. Food and Drug Administration has cleared BTL’s Emsculpt Ne o for use in stimulating neuromuscular tissue for bulk muscle excitation in the legs or arms for rehabilitative purposes. Emsculpt Neo is now cleared for: Prevention or retardation of disuse atrophy Muscle re-education Maintaining or increasing range of motion Immediate post-surgical prevention of calf muscles to prevent venous thrombosis Relaxation of muscle spasms Increasing local blood circulation “This FDA clearance op
36 
Let's personalize your content